Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Retatrutide is investigational and has never been FDA-approved, so no licensed pharmacy or provider dispenses it as an authorized product
You receive 2 BPC-157 vials , 2 TB-500 vials , 1 GHK-Cu vial , and 1 KPV vial , supplied separately as lyophilised solids
Measure against baseline weekly
In clinical practice, treatment may be guided by dominant cardiometabolic phenotype, with early combination therapy considered in individuals at high risk or with overlapping disease domains
US$ 29.36
.webp)
US$ 25.75
US$ 22.23
US$ 28.70
